Genetic variation and inflammation intersections: GATA2- and RUNX1-linked mechanisms of blood pathogenesis
Experimental Hematology · 2026-06 · 158 · 105405
DOI: 10.1016/j.exphem.2026.105405 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Hematology, 2026-06. Verfasst von Vu L Tran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wisconsin Blood Cancer Research Institute, Department of Cell and Regenerative Biology, Carbone Cancer Center, University of Wisconsin School of Medi…. Hauptthemen laut MEDLINE: GATA2 Transcription Factor, Core Binding Factor Alpha 2 Subunit, Inflammation, Genetic Variation. Die Arbeit nennt 224 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Germline genetic variation can predispose hematopoietic stem and progenitor cells to bone marrow failure and hematologic malignancies. Why predisposition-causing (conditionally pathogenic, CP) genetic variation is insufficient for pathogenesis is incompletely understood. The current paradigm assumes that CP variation enables secondary genetic mutations and/or epigenetic alterations to instigate pathogenesis. Hematopoietic stem/progenitor cells harboring CP variation can exhibit dysregulated expression of genes encoding inflammatory signaling components. Given the positive and negative autoregulatory loops intrinsic to inflammatory signaling networks, exposing such cells to inflammation would further corrupt the networks and genome function, predisposing cells to malignant transformation. There are many unanswered questions on how signaling machinery alterations impact signaling networks governing genome function in the basal state and in a microenvironment with qualitatively and/or quantitatively aberrant inflammation. Corrupted signaling networks caused by the deleterious combination of inflammation and CP variation intersect with and disrupt physiological mechanisms governing hematopoietic stem and progenitor cell genome function. This review considers how inflammation triggers or amplifies the functional ramifications of CP variation as a blood pathogenic mechanism, with a particular emphasis on GATA2 and RUNX1 transcription factor-linked mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wisconsin Blood Cancer Research Institute, Department of Cell and Regenerative Biology, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
- Wisconsin Blood Cancer Research Institute, Department of Cell and Regenerative Biology, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address: ehbres…
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NIDDK
- National Institutes of Health
- National Institutes of Health National Cancer Institute
- National Heart Lung and Blood Institute
Zitieren
APA
Tran, V. L., Johnson, K. D., & Bresnick, E. H. (2026). Genetic variation and inflammation intersections: GATA2- and RUNX1-linked mechanisms of blood pathogenesis. Experimental Hematology, 158, 105405. https://doi.org/10.1016/j.exphem.2026.105405
Vancouver
Tran VL, Johnson KD, Bresnick EH. Genetic variation and inflammation intersections: GATA2- and RUNX1-linked mechanisms of blood pathogenesis. Experimental Hematology. 2026;158:105405. doi:10.1016/j.exphem.2026.105405
BibTeX
@article{Tran2026,
author = {Tran, Vu L and Johnson, Kirby D and Bresnick, Emery H},
title = {Genetic variation and inflammation intersections: GATA2- and RUNX1-linked mechanisms of blood pathogenesis},
journal = {Experimental Hematology},
year = {2026},
volume = {158},
pages = {105405},
doi = {10.1016/j.exphem.2026.105405}
}
EUVIMED